NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Current Deferred Revenue (2010 - 2013)

Updated

NovelStem International (NSTM) recorded Current Deferred Revenue of $82,451 in Q3 2021, down 21.1% from the prior quarter.

Analysis

NovelStem International (NSTM) Current Deferred Revenue (2010 - 2013) Analysis & Trends

At the end of FY2012, NovelStem International reported Current Deferred Revenue of $111,669, down 57.7% from FY2011.

  • Across earlier years, Current Deferred Revenue came in at $264,228 in FY2011 (-73.1%) and $980,786 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 NovelStem International 493,324.54 346,279.54 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 82,451.00
Jun 30, 2013 104,451.00
Mar 31, 2013 108,169.00
Dec 31, 2012 111,669.00
Sep 30, 2012 120,194.00
Jun 30, 2012 164,778.00
Mar 31, 2012 620,623.00
Dec 31, 2011 264,228.00
Sep 30, 2011 810,133.00
Jun 30, 2011 844,146.00
Dec 31, 2010 980,786.00
API Access

NovelStem International Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NSTM&period=max&api_key=YOUR_API_KEY